ICICI Securities Ltd | Retail Equity Research Revenues declined 10% YoY to | 3586 crore (I-direct estimate: | 3328 crore) mainly due to 13% decline in US sales to | 1613 crore (I-direct estimate: | 1518 crore). The US sales decline was primarily on account of increased competition in gValcyte and injectable franchise, coupled with pricing pressure and moderation in volumes off-take. RoW sales declined 55% YoY to | 123 crore primarily on account of absence of reported sales in Venezuela...